Patent Assignment
Reel/Frame 065281/0807
Assignment of Assignor's Interest
Recorded: 2023-10-19
Pages: 5
Assignor
PALLADIO BIOSCIENCES, INC.
Executed: 2023-10-06
Assignee
CENTESSA BIOSCIENCES, INC.
1 FEDERAL STREET, 38TH FLOOR, BOSTON, MASSACHUSETTS, 02110
Covered Properties
(5)
Compositions for Delivery of Insoluble Agents
Application:
13/403,902 →
Publication:
US 2012/0225118
Formulations of Lixivaptan for the Treatment of Polycystic Disease
Formulations of Lixivaptan for the Treatment of Polycystic Disease
Application:
17/560,469 →
Publication:
US 2022/0110944
Formulations of Lixivaptan for the Treatment of Polycystic Kidney Disease
Application:
62/517,793 →
Formulations of Lixivaptan for the Treatment of Polycystic Disease
Application:
62/580,167 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 24, 2018
From: PELLEGRINI, LORENZO
To: PALLADIO BIOSCIENCES, INC.
Reel/Frame 045897/0751 →
Assignment of Assignor's Interest
May 27, 2021
From: PELLEGRINI, LORENZO
To: PALLADIO BIOSCIENCES, INC.
Reel/Frame 056367/0214 →
Security Interest
Oct 4, 2021
From: APCINTEX LIMITED; JANPIX LIMITED; CAPELLA BIOSCIENCE LTD; LOCKBODY THERAPEUTICS LTD
To: COCOON SA LLC
Reel/Frame 057710/0082 →
Assignment of Assignor's Interest
Jul 19, 2022
From: PELLEGRINI, LORENZO
To: PALLADIO BIOSCIENCES, INC.
Reel/Frame 060546/0131 →
Release of Security Interest
Dec 30, 2024
From: COCOON SA LLC
To: CARDIOKINE BIOPHARMA LLC; CENTESSA BIOSCIENCES, INC.; APCINTEX LIMITED; Z FACTOR LIMITED
Reel/Frame 069702/0875 →